Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–10 of 10 trials
Active filters
Clinical trials found
Published and searchable clinical trials
NCT07097363
- Conditions
- B-Cell Non-Hodgkin Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +23 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT04231877
- Conditions
- ALK-Positive Large B-Cell Lymphoma, Aggressive Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, +17 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT06550141
- Conditions
- Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +16 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment
NCT06784167
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +33 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
NCT06238648
- Conditions
- Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
- Siteman Cancer Center at Washington University St Louis, Missouri, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
- Memorial Sloan Kettering Cancer Center New York, United States
Epcoritamab and Pola-R-mini-CHP for the Treatment of Diffuse Large B Cell Lymphoma in Elderly or Unfit Patients
NCT07714421
- Conditions
- Diffuse Large B-cell Lymphoma, Grade 3b Follicular Lymphoma, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
NCT00001337
- Conditions
- Anaplastic Large-Cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +21 more
- Locations
-
- Holy Cross Hospital, Fort Lauderdale Fort Lauderdale, Florida, United States
- University of Maryland, Baltimore Baltimore, Maryland, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- Brigham and Women's Hospital Boston, Massachusetts, United States
NCT01897571
- Conditions
- Advanced Solid Tumors (Phase 1), B-cell Lymphomas (Phase 1), Diffuse Large B-cell Lymphoma (Phase 2), +15 more
- Locations
-
- Birmingham, Alabama, United States
- Duarte, California, United States
- Santa Barbara, California, United States
- Aurora, Colorado, United States
NCT00532259
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
- Locations
-
- Moores UCSD Cancer Center La Jolla, California, United States
- Scripps Cancer Center San Diego, California, United States
- Emory University-Winship Cancer Institute Atlanta, Georgia, United States
- Northside Hospital Atlanta, Georgia, United States
Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
NCT04759586
- Conditions
- Primary Mediastinal Large B-Cell Lymphoma
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- USA Health Strada Patient Care Center Mobile, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States